• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    More On CANF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Can-Fite BioPharma Ltd. (CANF)

    -NYSE MKT
    3.00 Down 0.29(8.81%) Jan 23, 4:02PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   467  
    Cost of Revenue -   -   -  
    Gross Profit -   -   467  
    Operating Expenses
    Research Development4,434  3,527  3,392  
    Selling General and Administrative4,587  2,485  1,813  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (9,021) (6,012) (4,738)
    Income from Continuing Operations
    Total Other Income/Expenses Net216  145  (2,570)
    Earnings Before Interest And Taxes(8,805)(5,867)(7,308)
    Interest Expense69  7  61  
    Income Before Tax(8,874)(5,874)(7,369)
    Income Tax Expense3  3  50  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(8,877)(5,877)(7,419)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (8,877) (5,877) (7,419)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (8,877) (5,877) (7,419)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.